Baird Medical Investment Holdings Limited
BDMD
$3.14
$0.051.62%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | ||
|---|---|---|---|---|---|
| Revenue | 20.03% | 20.03% | 13.77% | 13.77% | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | 20.03% | 20.03% | 13.77% | 13.77% | |
| Cost of Revenue | 25.33% | 25.33% | -19.45% | -19.45% | |
| Gross Profit | 19.38% | 19.38% | 20.92% | 20.92% | |
| SG&A Expenses | -1.17% | -1.17% | 3.58% | 3.58% | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | 23.83% | 23.83% | -5.91% | -5.91% | |
| Operating Income | 15.31% | 15.31% | 70.01% | 70.01% | |
| Income Before Tax | -2.03% | -2.03% | 65.35% | 65.35% | |
| Income Tax Expenses | -9.92% | -9.92% | -17.32% | -17.32% | |
| Earnings from Continuing Operations | -0.97% | -0.97% | 85.78% | 85.78% | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -13.93% | -13.93% | -82.11% | -82.11% | |
| Net Income | -1.12% | -1.12% | 85.81% | 85.81% | |
| EBIT | 15.31% | 15.31% | 70.01% | 70.01% | |
| EBITDA | 13.75% | 13.75% | 66.83% | 66.83% | |
| EPS Basic | -1.11% | -1.11% | 85.86% | 85.86% | |
| Normalized Basic EPS | -2.32% | -2.32% | 64.94% | 64.94% | |
| EPS Diluted | -0.27% | -0.27% | 85.86% | 85.86% | |
| Normalized Diluted EPS | -2.92% | -2.92% | 64.94% | 64.94% | |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | |
| Average Diluted Shares Outstanding | 0.67% | 0.67% | 0.00% | 0.00% | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |